CEMIX Performance — Causeway Emerging Markets Fund, Institutional Class
Data updated: 2026-08-28
CEMIX returned +31.28% year to date and +53.29% over one year to Jun 2026. Annualised returns are +29.99% over 3 years and +10.99% over 5 years. The fund beat its Emerging Markets Equity category average: $100 invested three years ago grew to $220, against $179 for the category, and to $153 over one year, against $141. Volatility over the past three years was 16.94% a year. In the 12 months to Jun 2026 the fund took in a net $569.0M, and assets reached $4.22B.
CEMIX Growth of $100
What $100 invested in Causeway Emerging Markets Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Emerging Markets Equity category average over the same months.
| Period | CEMIX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $153 | $141 |
| 3 years (Jul 2023 – Jun 2026) | $220 | $179 |
| 5 years (Jul 2021 – Jun 2026) | $168 | $144 |
| Since data start (Jul 2019 – Jun 2026) | $229 | $195 |
CEMIX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +31.28% |
| 1 year | +53.29% |
| 3 years (annualised) | +29.99% |
| 5 years (annualised) | +10.99% |
CEMIX Annual Returns
Calendar-year total returns of Causeway Emerging Markets Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +31.28% |
| 2025 | +36.19% |
| 2024 | +14.94% |
| 2023 | +17.33% |
| 2022 | −23.02% |
| 2021 | −1.30% |
| 2020 | +16.94% |
| 2019 (Jul–Dec) | +7.06% |
CEMIX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −10.3% | +6.9% | +9.3% | −0.6% | +9.2% | +15.4% | — | — | — | — | — | — |
| 2025 | +1.3% | −0.4% | −0.3% | +8.6% | +6.2% | +0.5% | +5.1% | +3.3% | +1.2% | +3.8% | −2.4% | +4.9% |
| 2024 | +2.4% | +5.4% | −0.2% | +3.9% | +2.8% | +2.2% | +5.0% | −0.5% | −0.4% | +0.1% | −2.2% | −3.9% |
| 2023 | +3.7% | −6.5% | +8.3% | +5.9% | −1.4% | +0.1% | −0.6% | −5.0% | +5.6% | +4.5% | +8.0% | −5.0% |
| 2022 | −3.2% | −4.5% | −0.3% | −8.9% | +0.6% | −5.1% | −11.8% | +0.5% | +0.9% | −3.2% | +13.5% | −2.3% |
| 2021 | −0.9% | +2.1% | +3.7% | +1.1% | +0.7% | +1.7% | −4.7% | +1.0% | −5.6% | +3.7% | −4.5% | +0.8% |
| 2020 | −14.3% | −4.5% | −6.0% | +5.8% | +1.3% | +8.6% | −1.0% | +1.3% | +9.0% | +8.4% | +8.0% | +2.0% |
| 2019 | — | — | — | — | — | — | +2.2% | −4.4% | −2.3% | +7.6% | +0.4% | +3.8% |
CEMIX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 16.94%
- 3-year Sharpe ratio: 1.50 (vs 4.5% risk-free rate)
- Best month: +15.39% (Jun 2026)
- Worst month: −10.31% (Jan 2026)
CEMIX Fund Flows
Monthly money in and out of Causeway Emerging Markets Fund, from SEC Form N-PORT.
- 12-month net flow: $569.0M
- 12-month gross sales (incl. reinvestments): $1.4B
- Sales ÷ redemptions: 1.67×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $161.7M | $68.9M | $92.8M |
| May 2026 | $66.0M | $139.3M | −$73.3M |
| Apr 2026 | $143.4M | $89.9M | $53.5M |
| Mar 2026 | $140.6M | $44.0M | $96.6M |
| Feb 2026 | $138.2M | $110.3M | $27.9M |
| Jan 2026 | $133.9M | $109.9M | $23.9M |
| Dec 2025 | $70.1M | $56.8M | $13.3M |
| Nov 2025 | $188.6M | $42.2M | $146.4M |
| Oct 2025 | $155.6M | $57.6M | $98.0M |
| Sep 2025 | $111.5M | $62.1M | $49.4M |
| Aug 2025 | $45.8M | $20.6M | $25.2M |
| Jul 2025 | $59.8M | $44.5M | $15.2M |
CEMIX Assets Under Management
Net assets of Causeway Emerging Markets Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $4.22B |
| 2026-03-31 | $3.30B |
| 2025-12-31 | $3.01B |
| 2025-09-30 | $2.66B |
| 2025-06-30 | $2.33B |
| 2025-03-31 | $3.79B |
| 2024-12-31 | $2.03B |
| 2024-09-30 | $2.17B |
| 2024-06-30 | $1.90B |
| 2024-03-31 | $1.54B |
| 2023-12-31 | $1.18B |
| 2023-09-30 | $1.22B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.